Seagen Inc.
CD19 binding agents and uses thereof

Last updated:

Abstract:

This invention, among other things, relates to CD19 binding agents and methods of using such CD binding agents for treating disease.

Status:
Grant
Type:

Utility

Filling date:

14 Feb 2018

Issue date:

17 May 2022